Breeze: an integrated quality control and data analysis application for high-throughput drug screening

• DOI: 10.1093/bioinformatics/btaa138
• Publication Date: 2020-02-26T20:18:20Z
• Authors: Swapnil Potdar; Aleksandr Ianevski; John-Patrick Mpindi; Dmitrii Bychkov; Clément Fiere; Philipp Ianevski; Bhagwan Yadav; Krister Wennerberg; Tero Aittokallio; Olli Kallioniemi; Jani Saarela; Päivi Östling
• Keywords: ta113; Data Analysis; Quality Control; ta112; 0303 health sciences; Computer and information sciences; ta111; Drug Evaluation, Preclinical; ta3111; Applications Notes; 3. Good health; 03 medical and health sciences; CELLS; Humans; Biochemistry, cell and molecular biology; Mathematics; Software

Abstract

Summary High-throughput screening (HTS) enables systematic testing of thousands of chemical compounds for potential use as investigational and therapeutic agents. HTS experiments are often conducted in multi-well plates that inherently bear technical and experimental sources of error. Thus, HTS data processing requires the use of robust quality control procedures before analysis and interpretation. Here, we have implemented an open-source analysis application, Breeze, an integrated quality control and data analysis application for HTS data. Furthermore, Breeze enables a reliable way to identify individual drug sensitivity and resistance patterns in cell lines or patient-derived samples for functional precision medicine applications. The Breeze application provides a complete solution for data quality assessment, dose–response curve fitting and quantification of the drug responses along with interactive visualization of the results.

Availability and implementation The Breeze application with video tutorial and technical documentation is accessible at https://breeze.fimm.fi; the R source code is publicly available at https://github.com/potdarswapnil/Breeze under GNU General Public License v3.0.

Contact [e-mail]

Supplementary information Supplementary data are available at Bioinformatics online.